Drugs / HRXG-K-1939
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05942378 | Jul 2023 → Sep 2025 | cancer | Fudan University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRXG-K-1939 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05942378 ↗ |
| Modality | Messenger RNA (mRNA) | “HRXG-K-1939 is a mRNA cancer vaccines” NCT05942378 ↗ |